Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
about
A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cellsAdeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectorsCell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells.Adeno-associated virus for cystic fibrosis gene therapyImmunology of AAV-Mediated Gene Transfer in the EyePredictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approachStructure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene TransferDirected evolution of adeno-associated virus yields enhanced gene delivery vectors.Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transferDifferent tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapySites in the AAV5 capsid tolerant to deletions and tandem duplications.Cationic lipid formulations alter the in vivo tropism of AAV2/9 vector in lungAAV's anatomy: roadmap for optimizing vectors for translational successComparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9.Long-term efficacy following readministration of an adeno-associated virus vector in dogs with glycogen storage disease type IaCytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuriaEpidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6.Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype.Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer.Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.Systemic delivery of genes to striated muscles using adeno-associated viral vectors.Pseudotyped AAV vector-mediated gene transfer in a human fetal trachea xenograft model: implications for in utero gene therapy for cystic fibrosis.Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1Synthetic virology: engineering viruses for gene deliveryParvovirus-mediated gene transfer for the haemophilias.Pre-immunization with an intramuscular injection of AAV9-human erythropoietin vectors reduces the vector-mediated transduction following re-administration in rat brainNoninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trialHigh-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung.Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brainAdeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered.Current status of gene therapy for inherited lung diseasesImmunological hurdles to lung gene therapy.Immune responses to adeno-associated virus and its recombinant vectors.Receptor targeting of adeno-associated virus vectors.
P2860
Q21142728-F05CDA8A-FCE9-452A-A121-7468F1058987Q24529153-2DCFED12-1BA1-4001-AAFE-3CAAACF5E784Q24538924-ADF888F9-0ECE-42E1-A2B1-968FF8F685A3Q26823156-F6D7858B-9F54-4348-A659-2E78CBD752F2Q27023474-7DDCA998-41D5-4EAB-B77E-F7D5BE627F38Q27324340-F845CAC0-CDE7-436B-AA73-E1680CA416F7Q27681034-872CCB19-4525-4108-8A93-7C65B67050EEQ30152887-B9CDD5D4-03FB-4A5B-9613-2CA4CF619435Q33232270-53480CF4-85C9-44DD-BFA1-DF86D77EBACDQ33296224-B8A99620-4234-4C9C-A471-37F20D7C8274Q33386030-97B5CB92-7FBA-41D3-A1CC-5E102987B043Q33526697-00CF9CF8-DF20-4503-9AD8-20316C135C3EQ33622758-F9989669-D977-4561-91C8-EE8B946E7008Q33659389-B1542F8B-9F9D-4920-ABC6-D8A3E2FBC872Q33713259-548B6204-381C-4829-A513-D4D91DBB167BQ33720634-E87A1E3D-C7B4-4ABF-8AB5-F59C7D9EBDFDQ33792012-5589D543-2BE7-49B7-A0A4-76A885FC64A8Q33832790-F792D8A7-4B47-4337-9F8B-DECA5F523492Q33913409-962E1FCC-5717-4E1B-A6AC-2F684C7B9E4BQ34193457-9C64BC28-894B-41B0-ACF3-4A336E69DF5CQ34233154-775A51E1-0811-4A57-B37F-16BE26B709F0Q34325086-84716355-E761-4B90-A464-0EAE576BE8EAQ34335296-3DF4DDEA-4E29-4A62-B8FB-B4F0DACC1632Q34342913-E5A3F2AB-C571-4036-A233-787200145465Q34347199-E400E282-7804-4E54-827C-F690231AA892Q34399258-07498BE0-D3DF-4812-BBB2-12D3D0CE581DQ34434903-46AF45C5-2467-4406-8CCD-F699CD50E401Q34487264-BBB2A774-71A6-430B-B698-6EE024095F70Q34609626-F68D2E6C-DAAB-4C25-8C71-7FE9A8B92F77Q34718452-8286C733-C187-4DBE-ADA5-572E8066B90DQ34777289-CA953E43-0F7E-4302-A5A6-47F54E240ECDQ34843808-0CD5A7E4-2BC6-4F7D-9405-FAE06E7EA6FFQ34845196-0824374B-5E33-420F-8E22-E407551C9C8BQ34938807-B4FA81F2-40AC-4411-83DE-D2F98BEE73F6Q35000819-61A4FB2A-F728-48D1-8DB0-8C548151A211Q35016463-3060A5A4-3472-46AB-AFFD-B4065BE25A5AQ35043830-7B30CF85-EEEF-4B86-9884-F4BF6EF28B4AQ35091006-B780D73A-1FBD-46C3-9CD0-EA31EFC33FA7Q35131229-74770D18-BAA7-46F8-9CB7-F79FD1058F72Q35165723-8AE328F0-18DF-4F02-BD54-9FE11A59C9B3
P2860
Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Repeat transduction in the mou ...... ctors with different serotypes
@ast
Repeat transduction in the mou ...... ctors with different serotypes
@en
type
label
Repeat transduction in the mou ...... ctors with different serotypes
@ast
Repeat transduction in the mou ...... ctors with different serotypes
@en
prefLabel
Repeat transduction in the mou ...... ctors with different serotypes
@ast
Repeat transduction in the mou ...... ctors with different serotypes
@en
P2093
P2860
P1433
P1476
Repeat transduction in the mou ...... ctors with different serotypes
@en
P2093
A D Miller
C L Halbert
D W Russell
E A Rutledge
P2860
P304
P356
10.1128/JVI.74.3.1524-1532.2000
P577
2000-02-01T00:00:00Z